Impact of Sex Hormones on Susceptibility to Autoimmune Inflammatory Diseases
Researchers studied the effect of sex hormones on immune phenotype in healthy individuals and those with autoimmune inflammatory diseases.
Pediatrics
Diacomit Approved for Younger Patients With Dravet Syndrome
Diacomit is available as 250mg and 500mg strength capsules in 60-count bottles and as fruit-flavored powder packets for oral suspension in 60-count cartons.
Pedmark Approved for Pediatric Cisplatin-Associated Ototoxicity
The approval was based on data from 2 pivotal phase 3 trials, which evaluated Pedmark in pediatric patients undergoing treatment with cisplatin-based chemotherapy.
FDA Warns of New Social Media Challenge With OTC Cough, Cold Medications
In a recent social media video challenge, individuals were encouraged to cook chicken in NyQuil or another similar OTC cough and cold medication.
Sensorineural Hearing Loss Risk in Children Tied to Oral Macrolide Therapy
Researchers sought to evaluate the risk for hearing loss with outpatient use of oral macrolide therapy in children, adolescents, and young adults.
Lomecel-B Granted Fast Track Status for Hypoplastic Left Heart Syndrome
Lomecel-B is delivered via intramyocardial injection.
DEA: “Rainbow Fentanyl” a Deliberate Tactic to Target Young People
Brightly colored versions of the synthetic opioid fentanyl are appearing across the US, according to the Drug Enforcement Administration (DEA). In a press statement, the Agency reported that the colorful fentanyl, dubbed “rainbow fentanyl”, has been seized in 18 different states and has been found in multiple forms, including pills, powder, and blocks that resemble…
Amoxicillin Remains Most Effective First-Line Treatment for Acute Otitis Media
Researchers compared the effects of amoxicillin with other broad-spectrum antibiotics on the risk for treatment failure and reinfection in children with uncomplicated acute otitis media.
FDA Authorizes Use of Novavax COVID-19 Vaccine, Adjuvanted in Adolescents
The FDA has expanded the EUA for the Novavax COVID-19 Vaccine, Adjuvanted to include adolescents 12 to 17 years of age to prevent COVID-19.
Behavioral Therapy Tied to Reduced Tic Severity in Youth With Tourette Syndrome
Researchers sought to determine the long-term durability of CBIT in youth with Tourette syndrome and persistent motor or vocal tic disorders.
- Loading...
Loading...
Next post in Pediatrics
Loading... 
Loading...